| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 1.915 | 4.844 | 3.366 | 8.088 |
| Total Income - EUR | - | - | - | - | - | - | 1.915 | 4.844 | 3.368 | 8.088 |
| Total Expenses - EUR | - | - | - | - | - | - | 991 | 1.010 | 3.069 | 5.102 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 923 | 3.834 | 299 | 2.986 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 866 | 3.689 | 179 | 2.596 |
| Employees | - | - | - | - | - | - | 1 | 1 | 0 | 0 |
Check the financial reports for the company - M&R Nefrologie S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 35 | 35 | 35 | 35 |
| Current Assets | - | - | - | - | - | - | 2.067 | 4.626 | 5.362 | 9.304 |
| Inventories | - | - | - | - | - | - | 112 | 398 | 943 | 995 |
| Receivables | - | - | - | - | - | - | 1.915 | 993 | 440 | 2.787 |
| Cash | - | - | - | - | - | - | 40 | 3.235 | 3.979 | 5.523 |
| Shareholders Funds | - | - | - | - | - | - | 906 | 4.598 | 4.763 | 7.332 |
| Social Capital | - | - | - | - | - | - | 0 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 1.195 | 62 | 634 | 2.006 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - M&R Nefrologie S.r.l.